40 results on '"Kassar, Olfa"'
Search Results
2. Hemophilia in the south of Tunisia
3. PB1749: COMPARATIVE STUDY OF B AND T-ALL IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS: CLINICAL CHARACTERISTICS AND THERAPEUTIC RESULTS
4. PB1907: EPIDEMIOLOGICAL PROFILE AND DIAGNOSTIC FEATURES OF ACUTE MYELOBLASTIC LEUKEMIA IN ADULTS: EXPERIENCE OF THE HEMATOLOGY DEPARTMENT OF SFAX
5. PB2369: PERIPHERAL T CELL LYMPHOMA: EPIDEMIOLOGY AND CLINICAL CHARACTERISTICS
6. PB1732: CLINICAL CHARACTERISTICS AND THERAPEUTIC RESULTS OF CHILDHOOD AND YOUNG ADULTS T - ACUTE LYMPHOBLASTIC LEUKEMIA IN SOUTH OF TUNISIA
7. PB1891: EARLY DEATH IN ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA
8. PB2367: CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH NODAL PERIPHERAL T-CELL LYMPHOMA
9. PB2650: ALLOANTIBODIES IN VON WILLEBRAND DISEASE: ABOUT 6 CASES IN SOUTHERN TUNISIA
10. PB1876: SIXTEEN YEARS OF EXPERIENCE WITH THE MRC-10 PROTOCOL FOR THE TREATMENT OF ADULT ACUTE MYELOID LEUKEMIA IN THE SOUTH OF TUNISIA
11. PB1895: CHARACTERISTICS AND OUTCOME OF PEADIATRIC ACUTE PROMYELOCYTIC LEUKEMIA IN SOUTHERN TUNISIA
12. Non-Hodgkin's lymphoma developed during imatinib mesylate treatment of chronic myeloid leukemia
13. Lack of FLT3-ITD in Tunisian childhood acute lymphoblastic leukemia
14. Life threatening hepatotoxicity induced by Nilotinib
15. Life threatening hepatotoxicity induced by Nilotinib.
16. Spontaneous Fracture and Migration of a Totally Implanted Port Device to Pulmonary Artery in Acute Leukemia Child
17. Assessment of molecular response to tyrosine kinase inhibitors in Tunisian Patients with Chronic Myeloid Leukemia.
18. Non-Hodgkin's lymphoma developed during imatinib mesylate treatment of chronic myeloid leukemia.
19. Assessment of molecular response to tyrosine kinase inhibitors in Tunisian Patients with Chronic Myeloid Leukemia
20. Aplastic anemia secondary to tyrosine kinase inhibitor therapy in a patient with chronic myeloid leukemia
21. La leucémie à plasmocytes primitive : quelle place pour la cytométrie en flux ?
22. Prospective observational study of palliative care in hematological malignancies: Report of one year of practice
23. Aplastic anemia secondary to tyrosine kinase inhibitor therapy in a patient with chronic myeloid leukemia.
24. Co-existence of BCR-ABL and JAK2V617F mutation in resistant chronic myeloid leukemia in the imatinib era: Is there a correlation?
25. Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia
26. Epidemiological characteristics of congenital bleeding disorders in south Tunisia
27. Patient Care Strategies for alloant-ibodies in Type 3 Von Willebrand Disease: A Southern Tunisia Perspective
28. Hypersensitivity pneumonitis related to imatinib mesylate therapy in a patient with chronic myeloid leukemia.
29. Acute acalculous cholecystitis complicating chemotherapy for acute myeloblastic leukemia
30. Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion
31. Syndrome de Klinefelter révélé par une leucémie aiguë myéloblastique
32. Complexity of diagnosing and treating langerhans cell sarcoma: A case report.
33. Cerebral venous thrombosis after first Methotrexate administration by lumbar puncture in a patient with large B cell lymphoma.
34. Primary plasma cell leukemia: what role does flow cytometry play?
35. Isolated optic nerve infiltration as a site of relapse of acute lymphoblastic leukemia.
36. Chronic myeloid leukemia following the treatment of nasopharyngeal carcinoma.
37. [Primary manifestation of small Lymphocytic Lymphoma in the Prostate: A case report].
38. [Primary immune thrombocytopenia in childhood: a regional study in the south of Tunisia].
39. [Gaucher disease type 1 in late onset].
40. [Klinefelter syndrome and acute myeloblastic leukaemia].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.